Xcelerating Life Sciences Boston Will Explore Biopharma’s Future in Digital Health

Xconomy Boston — 

Join Xconomy on April 29 at Takeda Pharmaceuticals’ Boston location for the next in our Xcelerating Life Sciences event series: Biopharma’s Future in Digital Health. The half-day conference will bring together innovators, executives, rising pioneers, entrepreneurs, investors, and scientists to examine what’s fueling Boston’s biotech investment and partnership opportunities.

As the nation’s largest biopharma cluster, Boston has a proven track record of life science leadership, including emerging therapeutics. Digital technologies will play a critical role in the expansion of this industry poised to grow more than $350 billion in the next five years. Great progress has been made, but significant scientific, technological, financial, and regulatory challenges remain. We’ll take a closer look at what’s been accomplished and address how to handle the hurdles that lie ahead.

Early bird tickets are on sale now for only $199. Grab yours today before prices go up.

Xconomy’s Xcelerating Life Sciences forums are dedicated to helping industry leaders develop meaningful partnerships and explore bold new ideas to overcome healthcare’s biggest challenges. Can’t make the Boston event? You can also join us in San Diego, New York, Philadelphia, San Francisco, and Seattle.

Sign up for alerts about Xcelerating Life Sciences events.